ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0962

Variability in Racial Disparities in Pregnancy Outcomes in Women with SLE by Diagnosis Algorithm

Megan Clowse1, Jim Oates2, Katie Kirchoff2, April Barnado3, Saira Sheikh4, Leslie Crofford3 and Amanda Eudy5, 1Duke University, Durham, NC, 2Medical University of South Carolina, Charleston, SC, 3Vanderbilt University Medical Center, Nashville, TN, 4University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Duke University, Raleigh, NC

Meeting: ACR Convergence 2022

Keywords: pregnancy, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Disparities in pregnancy outcomes among women with SLE remain understudied, with few available racially-diverse datasets. We previously validated algorithms to identify pregnancies in women with SLE within the electronic medical record (EMR) of tertiary care centers in the Southern United States, finding the algorithms more accurate for Black than White women with SLE: there was a high rate of SLE over-labeling in White women, particularly by physicians other than rheumatologists. In this study, we analyzed differences in pregnancy outcomes based on different algorithm definitions of SLE pregnancies in Black and White patients with SLE.

Methods: Using the Common Data Model EMR-based datasets within the Carolinas Collaborative (Sites A, B, and C), we identified women with pregnancy delivery data (2014-2019) and ≥1 SLE ICD9/10 code. From this dataset, we identified four cohorts of SLE pregnancies, 3 using different algorithms and one via chart review to confirm SLE diagnosis. We compared the pregnancy outcomes identified in each of these cohorts for Black and White women. All pregnancies identified using the sensitive algorithm from Sites A and B were included in the chart review; chart review was not possible for Site C data.

Sensitive algorithm: 1 ICD-9/10 code for SLE prior to delivery.

Predictive algorithm: ≥4 ICD9/10 codes + HCQ for SLE.

XG Boost: a machine learning-derived algorithm validated for Black and White women with SLE.

Confirmed: Chart reviewed for SLE.

Results: Of 172 pregnancies in women with ≥1 SLE ICD9/10 code (Sensitive algorithm, sites A & B), 55% had SLE by the Predictive algorithm (44% of White and 61% of Black women), 53% by the XG Boost algorithm (34% of White and 65% of Black women), and 49% had SLE confirmed by chart review (34% of White and 62% of Black women). Overall, adverse pregnancy outcomes occurred in 40% of pregnancies in women with ≥1 ICD9/10 SLE code and 52% of pregnancies with confirmed SLE (Figure 1 for Sites A&B and Table 1 for Site C). SLE was frequently over-diagnosed in women who were White, resulting in 40-75% lower rates of adverse pregnancy outcomes in cohorts identified using algorithms vs. the confirmed cohort. Over-diagnosis of SLE was less common for Black women resulting in pregnancy outcomes 12-20% lower in algorithm-derived vs. confirmed SLE cohorts. While the EMR algorithms suggested significantly higher rates of adverse pregnancy outcomes in Black than White women, these disparities were smaller and no longer significant in the cohorts of women confirmed through chart review (Table 2).

Conclusion: Within these university hospitals in the southeastern US, pregnancy outcomes for Black and White women with confirmed SLE were similar. The over-diagnosis of SLE in White women led the algorithms to include women without SLE, which caused large under-estimations of their pregnancy risk. As Black women in this study were more accurately labeled for SLE, the algorithms identified more accurate estimates of pregnancy risk. This study suggests that race-based differences in algorithm performance can impact our understanding of racial disparities in SLE.

Supporting image 1

Figure 1: The frequency of adverse pregnancy outcomes in the different cohorts of women with SLE, defined by EMR-based algorithm (Sensitive, Predictive, and XG Boost) or confirmed by chart review (Sites A & B).

Supporting image 2

Table 1: Pregnancy outcomes in Site C (chart review was not available). The shifts in algorithm accuracy and pregnancy outcomes was similar between the Sensitive and Predictive cohorts in Site C as in Sites A and B.

Supporting image 3

Table 2: Racial Disparities in Pregnancy Outcomes. While the EMR algorithms suggest significantly higher rates of adverse pregnancy outcomes in Black than White women, these disparities are smaller and no longer significant in the cohorts of women confirmed through chart review.


Disclosures: M. Clowse, Exagen; J. Oates, None; K. Kirchoff, None; A. Barnado, None; S. Sheikh, GlaxoSmithKlein(GSK), AstraZeneca, Eli Lilly, Pfizer, Aurinia Pharmaceuticals Inc.; L. Crofford, None; A. Eudy, GlaxoSmithKlein(GSK), Pfizer, Exagen.

To cite this abstract in AMA style:

Clowse M, Oates J, Kirchoff K, Barnado A, Sheikh S, Crofford L, Eudy A. Variability in Racial Disparities in Pregnancy Outcomes in Women with SLE by Diagnosis Algorithm [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/variability-in-racial-disparities-in-pregnancy-outcomes-in-women-with-sle-by-diagnosis-algorithm/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/variability-in-racial-disparities-in-pregnancy-outcomes-in-women-with-sle-by-diagnosis-algorithm/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology